Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke (Q48593375)

13 February 2018

title

Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke (English)

1 reference

13 February 2018

1 reference

Eduardo Romanos

1

1 reference

13 February 2018

Anna M Planas

series ordinal

2

1 reference

13 February 2018

Sergio Amaro

series ordinal

3

1 reference

13 February 2018

Angel Chamorro

series ordinal

4

1 reference

13 February 2018

publication date

5 April 2006

1 reference

13 February 2018

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

13 February 2018

volume

27

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

14-20

1 reference

13 February 2018

Towards the physiological function of uric acid

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Yin and yang of uric acid in patients with stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Uric acid administration for neuroprotection in patients with acute brain ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Administration of transforming growth factor-alpha reduces infarct volume after transient focal cerebral ischemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Pilot Dose-Escalation Study of Caffeine Plus Ethanol (Caffeinol) in Acute Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Nitric oxide, oxidants, and protein tyrosine nitration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Uric acid protects against secondary damage after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Neuroprotective effects of YM872 coadministered with t-PA in a rat embolic stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

Antithrombotic and thrombolytic therapy for ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

inferred from DOI database lookup

7 January 2021

based on heuristic

Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

inferred from DOI database lookup

7 January 2021

based on heuristic

Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600312

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.JCBFM.9600312

1 reference

13 February 2018

1 reference

13 February 2018